Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT04933305 Completed - Obesity Clinical Trials

Microstructure of Ingestive Behavior and Body Weight Loss After Roux-en-Y Gastric Bypass

Drinkometer
Start date: April 1, 2019
Phase:
Study type: Observational

Studies of appetitive behavior in humans after RYGB have produced ambiguous results. It therefore remains unclear whether there are fundamental shifts in the palatability of high-fat and sugary foods after RYGB or simply a decrease in the appetitive drive to ingest them. Moreover, learning processes may play a role as changes in diet selection progress with time in rats after RYGB. However, direct measures of an altered food selection in humans after RYGB are rare and both the durability of the phenomenon as well as the role of experience for changes in food selection remain elusive.

NCT ID: NCT04914819 Completed - Weight Loss Clinical Trials

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

EMPOWER-Mom
Start date: June 18, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to test the feasibility and effectiveness of a 16-week online behavioral weight loss program compared to usual care to promote weight loss in the postpartum period among women with cardiovascular risk factors. The investigators will also be testing different behavioral strategies to recruit postpartum women to the study, including 2 email recruitment strategies and 2 mailer recruitment strategies, informed by behavioral design.

NCT ID: NCT04908332 Completed - Breastfeeding Clinical Trials

Effect of Kangaroo Baby Massage on Mother-infant Interaction at Home

KBM
Start date: July 22, 2021
Phase: N/A
Study type: Interventional

The objective of this randomized clinical trial will determine the effectiveness of nursing intervention (Kangaroo Baby Massage) on the interaction between mothers and premature, low birth weight infants at home The dyad mother- infant of the control group will receive Kangaroo position KP and the dyad mother- infant mothers of the intervention group will receive the Kangaroo Baby Massage KBM

NCT ID: NCT04907734 Completed - Body Weight Clinical Trials

Differences in Skinfold Thickness Depending on the Caliper Used.

Start date: February 1, 2021
Phase:
Study type: Observational

The present study aims to compare the results obtained from the assessment of skinfolds using four anthropometric calipers (Harpenden, Holtain, Slime Guide and Lipowise). The objectives are to check if there are differences depending on the caliper used to assess skinfolds, and to study the variation in skinfold compressibility as a function of the time elapsed from the application of the caliper to the measurement reading, as well as the validation of the Lipowise caliper. A cross-sectional study will be carried out with a sample of 100 university students aged between 18 and 25 years. Physical activity will be assessed by means of an International Physical Activity Questionnaire (IPAQ) and hydration status by urine samples. Anthropometric assessments, including weight, height, and eight skinfolds, will be performed according to the International Society for the Advancement in Kinanthropometry protocol, using the four previously mentioned calipers. Finally, a data analysis will be carried out to compare the results of the samples taken by the calipersand to draw conclusions.

NCT ID: NCT04904406 Completed - HIV Infections Clinical Trials

Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals

AVERTAS
Start date: October 22, 2020
Phase: Phase 4
Study type: Interventional

Randomized controlled parallel open-label study in people living with HIV and at least 6 month of treatment with dolutegravir/abacavir/lamivudine prior to inclusion. Participants (n=95) are randomized to continue 3 drug-regimen dolutegravir/abacavir/lamivudine (control) or switch to two-drug regimen with dolutegravir/lamivudine (intervention). Follow-up is 48 weeks. Data is collected at baseline and week 48. Primary outcome is changes in weight from baseline of more than 2 kg. Secondary outcomes are changes in cardiac risk, composition and calcification of the heart tissue, and changes in body composition and metabolism, inflammation and coagulation. A MRI substudy is applied to focus on the cardiac adverse effects of abacavir.

NCT ID: NCT04901949 Completed - Obesity Clinical Trials

The Course of Acute Pancreatitis in Patients With Different BMI Groups

Start date: September 20, 2020
Phase:
Study type: Observational

In obese (OB) patients, the presence of an increased inflammatory state in the body due to the increase in abdominal adipose tissue and increase in the frequency of gallstones and lipid levels are expected to increase the development of acute pancreatitis (AP). The effect of obesity on the clinical course of acute pancreatitis has much been attracted the attention of researchers. The aim of this study is to evaluate whether the prevalence and severity of AP, as well as Balthazar tomographic scoring, differs in BMI groups (normal, overweight, obese).

NCT ID: NCT04893772 Completed - Weight Loss Clinical Trials

Meal Timings, Appetite, Mood and Weight Loss in Individuals on a Commercial Intermittent Fasting Programme

DASMA
Start date: June 30, 2021
Phase:
Study type: Observational

Although individuals following commercial intermittent fasting programmes consume meal replacement products during fasting days, further behavioural variables such as time of food consumption, sleep quality and duration, appetite and mood may significantly impact weight loss and intervention success. This project aims to assess behavioural patterns (dietary intake, sleep, meal timing, physical activity), mood and appetite on both fasting and non-fasting days and to investigate whether these are associated with weight loss.

NCT ID: NCT04887584 Completed - Body Weight Clinical Trials

Pulse Biomarker Discovery

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Dietary pulses, including beans, chickpeas, and lentils, are high in soluble fiber with potential benefits to human health: Pulses are moderate energy density foods, low in fat and high in dietary protein, fiber, vitamins and minerals. Moderate pulse consumption is associated with improvements in glycemic control and reduced risk of cardiovascular disease, obesity and type 2 diabetes. Measuring pulse consumption in humans is difficult, due to limitations in current methods for dietary assessment which are largely based on dietary recalls that are subject to reporting bias. Robust tools for pulse intake assessment are needed, and biomarkers of dietary pulse intake are one approach to solve this problem. The goal of this human feeding study is evaluate the presence of biomarkers of dietary pulses in human subjects.

NCT ID: NCT04880486 Completed - Quality of Life Clinical Trials

Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Start date: September 18, 2019
Phase: N/A
Study type: Interventional

Using weight training with virtual reality can help after discharge patients of acute exacerbation of chronic obstructive pulmonary disease, which maintained their quality of life, and improved their exercise capacity, pulmonary function, readmission condition.

NCT ID: NCT04875091 Completed - Weight Loss Clinical Trials

Understanding Variability in Behavioral Weight Loss Treatment Response in Young Women (Ready SET Health)

Start date: July 28, 2021
Phase: N/A
Study type: Interventional

This study is a single-arm behavioral weight loss intervention for emerging adult women with in-person assessments at 0 (baseline) and 4 months (post-treatment) in addition to EMA data collection regarding risk factors known to interfere with program engagement and weight loss in this high-risk population (e.g., sleep, psychological distress, life events).